Company looks to expand the label of depression drug AXS-05, while bringing Alzheimer’s agitation its second mechanism

Syntrix is creating desmetramadol as a safer and less variable version of tramadol

How liquid biopsies could lead to the next big step in modeling dose levels for precision medicine.

Why diagnostic innovation needs Congress to fix patent law’s Section 101